2011 Fiscal Year Final Research Report
Cell fate decision mechanism by the transcription factor E2F in cell growth and tumor suppression
Project/Area Number |
21570180
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Molecular biology
|
Research Institution | Kwansei Gakuin University |
Principal Investigator |
|
Project Period (FY) |
2009 – 2011
|
Keywords | 細胞増殖 / 癌化抑制 / 細胞運命 / 転写因子 / アポトーシス / E2F / PI3キナーゼ / microRNA |
Research Abstract |
We analyzed the molecular mechanism of control of cell growth and tumor suppression mediated by the transcription factor E2F, the main target of the tumor suppressor pRB. We identified 5 novel genes, which are specifically activated by E2F induced by loss of pRB function, a representative oncogenic change. Many of these gene products are involved in the p53 pathway, which induces cell death. PI3 kinase pathway did not suppress activation of tumor suppressor genes by E2F induced by loss of pRB function.
|
Research Products
(20 results)
-
[Journal Article] Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation2012
Author(s)
Ma, T., Yamada, S., Ichwan, S., Iseki, S., Ohtani, K., Otsu, M., Ikeda, MA.
-
Journal Title
Biochem. Biophys. Res. Commun
Volume: (in press)
Peer Reviewed
-
[Journal Article] Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential2010
Author(s)
Ohno, Y., Yasunaga, S., Ohtsubo, M., Mori, S., Tsumura, M., Okada, S., Ohta, T., Ohtani, K., Kobayashi, M., and Takihara, Y.
-
Journal Title
Proc Natl Acad Sci USA
Volume: 107
Pages: 21529-21534
Peer Reviewed
-
[Journal Article] E2F-like elements in p27Kip1 promoter specifically sense deregulated E2F activity2009
Author(s)
Ozono, E., Komori, H., Iwanaga, R., Ikeda, MA., Iseki, S., and Ohtani, K.
-
Journal Title
Genes Cells
Volume: 14
Pages: 89-99
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-